Evidence map›Paper›PMID 25299165›Full record

ReviewCurrent opinion in pharmacology2014

Classical nuclear hormone receptor activity as a mediator of complex concentration response relationships for endocrine active compounds.

Clifford J Cookman, Scott M Belcher

Abstract readReview
In one paragraph

Review in Current opinion in pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Clifford J CookmanDepartment of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575, USA.
Scott M BelcherDepartment of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575, USA. Electronic address: scott.belcher@uc.edu.

Funding

ENVIRONMETAL CARCINOGENESIS AND MUTAGENESIST32ES007250 · NIEHS · UNIVERSITY OF CINCINNATI · PI MILLER, WILLIAM E · 1988 to 2024
$11.9M
Defining the Impact of Dietary Bisphenol A on Heart Health in the C57BL/6 MouseRC2ES018765 · NIEHS · UNIVERSITY OF CINCINNATI · PI BELCHER, SCOTT M · 2009 to 2010
$1.4M
Toxicokinetics and Metabolic Disrupting Actions of the Flame Retardant Mixture FMR56ES022957 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI BELCHER, SCOTT M, PATISAUL, HEATHER B · 2014 to 2014
$300k
Assessment of Cardiac End Points in the CLARITY-BPA StudyR03ES023098 · NIEHS · UNIVERSITY OF CINCINNATI · PI BELCHER, SCOTT M · 2013 to 2014
$158k
NIEHS NIH HHS R03 ES023098NIEHS NIH HHS R03ES023098NIEHS NIH HHS R56 ES022957NIEHS NIH HHS RC2 ES018765NIEHS NIH HHS RC2ES018765NIEHS NIH HHS T32 ES007250NIEHS NIH HHS T32ES007250
6 · The paper itself

Abstract

Nonmonotonic concentration response relationships are frequently observed for endocrine active ligands that act via nuclear receptors. The curve of best fit for nonmonotonic concentration response relationships are often inverted U-shaped with effects at intermediate concentrations that are different from effects at higher or lower concentrations. Cytotoxicity is a major mode of action responsible for inverted U-shaped concentration response relationships. However, evidence suggests that ligand selectivity, activation of multiple molecular targets, concerted regulation of multiple opposing endpoints, and multiple ligand binding sites within nuclear receptors also contribute to nonmonotonic concentration response relationships of endocrine active ligands. This review reports the current understanding of mechanisms involved in classical nuclear receptor mediated nonmonotonic concentration response relationships with a focus on studies published between 2012 and 2014.

Indexed as

AnimalsCell SurvivalDose-Response Relationship, DrugEndocrine DisruptorsHumansReceptors, Cytoplasmic and NuclearEndocrine DisruptorsReceptors, Cytoplasmic and Nuclear

Identifiers

PMID25299165
PMCPMC4260535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.